-+ 0.00%
-+ 0.00%
-+ 0.00%

Aura Biosciences prices USD 260.3 million stock, pre-funded warrant offering at USD 6

PUBT·05/04/2026 13:07:37
Listen to the news
Aura Biosciences prices USD 260.3 million stock, pre-funded warrant offering at USD 6
  • Aura Biosciences priced an underwritten public offering expected to raise USD 260.3 million in gross proceeds through sale of 39,591,000 common shares at USD 6 per share.
  • Offering also includes pre-funded warrants for up to 3,800,000 shares priced at USD 5.99999, with a USD 0.00001 exercise price.
  • Net proceeds earmarked for clinical programs, with remaining funds allocated to repurchase up to 6,922,870 shares from Matrix Capital Management Master Fund at USD 5.64 per share.
  • Underwriters hold a 30-day option to buy up to 6,508,650 additional shares on same terms.
  • Closing expected on or about May 5, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aura Biosciences Inc. published the original content used to generate this news brief on May 04, 2026, and is solely responsible for the information contained therein.